HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical study of the efficiency and safety of afala in patients with benign prostatic hyperplasia.

Abstract
The use of afala in patients with benign prostatic hyperplasia and moderate urination disturbances reduced the symptoms of the disease, improved urodynamic parameters, and increased quality of life. Clinical efficiency of afala was comparable with the efficiency of Serenoa repens extract (reference preparation).
AuthorsK V Savel'eva, M V Kachanova, V N Pavlov, R A Kazikhinurov, M Yu Frolov, A B Mukhin, V V Udut, Z A Yurmazov, Yu L Dugina, S A Sergeeva, O I Epshtein
JournalBulletin of experimental biology and medicine (Bull Exp Biol Med) Vol. 148 Issue 2 Pg. 305-7 (Aug 2009) ISSN: 1573-8221 [Electronic] United States
PMID20027354 (Publication Type: Journal Article, Randomized Controlled Trial)
Chemical References
  • Antibodies
  • Immunologic Factors
  • afala
Topics
  • Adult
  • Aged
  • Antibodies (adverse effects, pharmacology, therapeutic use)
  • Humans
  • Immunologic Factors (pharmacology, therapeutic use)
  • Male
  • Middle Aged
  • Prostatic Hyperplasia (drug therapy, pathology)
  • Quality of Life
  • Treatment Outcome
  • Urodynamics (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: